SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-22-005512
Filing Date
2022-02-24
Accepted
2022-02-24 18:05:59
Documents
1
Period of Report
2022-02-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 9475
  Complete submission text file 0001567619-22-005512.txt   10873
Mailing Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 650 325 5156
Imago BioSciences, Inc. (Issuer) CIK: 0001623715 (see all company filings)

IRS No.: 454915810 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address IMAGO BIOSCIENCES, INC. 329 OYSTER POINT BLVD. 3RD FL SOUTH SAN FRANCISCO CA 94080
Business Address
Eichorn Laura G. (Reporting) CIK: 0001861067 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40604 | Film No.: 22673380